Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections

Annals of Internal Medicine

Volumn 158, Issue 3, 2013, Pages 154-161

  Kerkering, Thomas M ^a   Grifasi, Marissa L ^a   Baffoe Bonnie, Anthony W ^a   Bansal, Ekta ^a   Garner, Dorothy C ^a   Smith, Jean A ^a   Demicco, Deborah D ^a   Schleupner, Charles J ^a   Aldoghaither, Rabia A ^a   Savaliya, Vipul A ^a  

^a VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; STEROID; VORICONAZOLE;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARACHNOIDITIS; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN VENTRICULITIS; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CLADOSPORIUM; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIDURAL ABSCESS; EXSEROHILUM ROSTRATUM; FEMALE; FUNGAL MENINGITIS; FUNGUS; HALLUCINATION; HUMAN; HYPONATREMIA; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEUTROPHILIC MENINGITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCREENING; SIDE EFFECT; TREATMENT RESPONSE; URINE RETENTION;

EID: 84873398197     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-3-201302050-00568     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. Meningitis and Stroke Associated with Potentially Contaminated Product. Atlanta, GA: Centers for Disease Control and Prevention; 2012. Accessed at http://emergency.cdc.gov/HAN /han00327.asp on 3 December 2012.
2. Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev. 2010;23:884-928. [PMID: 20930077]
3. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis. 2004;38:206-16. [PMID: 14699452]
4. Bennett JE, Dismukes WE, Duma RJ, Medoff G, Sande MA, Gallis H, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med. 1979;301:126-31. [PMID: 449951]
5. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992;326:83-9. [PMID: 1727236]
6. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med. 1997;337:15-21. [PMID: 9203426]
7. Adler A, Yaniv I, Samra Z, Yacobovich J, Fisher S, Avrahami G, et al. Exserohilum: an emerging human pathogen. Eur J Clin Microbiol Infect Dis. 2006;25:247-53. [PMID: 16511679]
8. Moja M, Muthuphei MN, van der Westhuizen LR, Gledhill RF. Multiple infarcts in a patient with cerebral phaeohyphomycosis: CT and MRI. Neuroradiology. 2000;42:261-6. [PMID: 10872169]
9. Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis. 2012;59:222-8. [PMID: 22001181]
10. Adam RD, Paquin ML, Petersen EA, Saubolle MA, Rinaldi MG, Corcoran JG, et al. Phaeohyphomycosis caused by the fungal genera Bipolaris and Exserohilum. A report of 9 cases and review of the literature. Medicine (Baltimore). 1986;65:203-17. [PMID: 3523112]
11. Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004. Mycoses. 2004;47:4-13. [PMID: 14998393]
12. Filizzola MJ, Martinez F, Rauf SJ. Phaeohyphomycosis of the central nervous system in immunocompetent hosts: report of a case and review of the literature. Int J Infect Dis. 2003;7:282-6. [PMID: 14656420]
13. Carter E, Boudreaux C. Fatal cerebral phaeohyphomycosis due to Curvularia lunata in an immunocompetent patient. J Clin Microbiol. 2004;42:5419-23. [PMID: 15528761]
14. Virginia Department of Health. Epidemiology Update: Fungal Infections Associated with Contaminated Product. Richmond, VA: Virginia Department of Health; 2012. Accessed at www.vdh.state.va.us/clinicians/pdf/Epi%20 Update%20for%20Clinicians%2011_19_2012.pdf on 3 December 2012.
15. Pettit AC, Kropski JA, Castilho JL, Schmitz JE, Rauch CA, Mobley BC, et al. The Index Case for the Fungal Meningitis Outbreak in the United States. N Engl J Med. 2012. [PMID: 23083311]
16. Centers for Disease Control and Prevention (CDC). Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy-United States, 2012. MMWR Morb Mortal Wkly Rep. 2012;61:839-42. [PMID: 23076093]
17. Lyons JL, Gireesh ED, Trivedi JB, Bell WR, Cettomai D, Smith BR, et al. Fatal Exserohilum meningitis and central nervous system vasculitis after cervical epidural methylprednisolone injection [Letter]. Ann Intern Med. 2012;157:835-6.
18. Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic/pharmacodynamic profile of voriconazole. Clin Pharmacokinet. 2006;45:649-63. [PMID: 16802848]
19. Pai MP, Lodise TP. Steady-state plasma pharmacokinetics of oral voriconazole in obese adults. Antimicrob Agents Chemother. 2011;55:2601-5. [PMID: 21422207]
20. da Cunha KC, Sutton DA, Gené J, Capilla J, Cano J, Guarro J. Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum. Antimicrob Agents Chemother. 2012;56:4951-4. [PMID: 22733074]
21. Li DM, de Hoog GS. Cerebral phaeohyphomycosis-a cure at what lengths? Lancet Infect Dis. 2009;9:376-83. [PMID: 19467477]